News

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...
“Cleveland Clinic: Millions of COVID-vaxxed will die within ‘5 years,’” the headline said. This Facebook post was flagged as ...
Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of ...
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
A team of researchers has uncovered a key cellular mechanism that affects the function of mRNA vaccines and therapeutics. Their study provides the first comprehensive understanding of how mRNA ...
Flu vaccines reduce the risk of GP presentation with influenza by 30-60 per cent and hospitalisation with influenza by 50-70 ...
A preprint study posted late last week on the server medRxiv reveals that the current Moderna COVID-19 vaccine is 53% ...
FRIDAY, April 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1, but the ...
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...
The surprise delay is casting new uncertainty on the fate of another vaccine awaiting FDA action: Moderna’s next-generation Covid-19 shot, called mRNA-1283, which is set for a decision by May 31.